May 6, 2020
Axcella gets positive data from AXA1125-003 study
Clinically relevant reductions in liver fat content, insulin resistance and fibroinflammation markers observed with AXA1125 along with favorable tolerability, supporting…
Pharmaceuticals, Biotechnology and Life Sciences
Clinically relevant reductions in liver fat content, insulin resistance and fibroinflammation markers observed with AXA1125 along with favorable tolerability, supporting…